GYRE - GYRE THERAPEUTICS, INC.
8.28
0.380 4.589%
Share volume: 100,514
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$7.90
0.00
0.00%
Summary score
49%
Profitability
48%
Dept financing
29%
Liquidity
75%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-75.16%
Return on assets
-8.38%
Return on sales
-255.59%
Return on invested capital
-172.8%
Total debt ratio
43.62%
Debt ratio change over timeo
-1.6%
Current Ratio
5.3%
Quick Ratio
5.1%
Cash Position Ratio
3.44%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
2.53%
Return on sales
10.8%
Return on invested capital
0%
Total debt ratio
43.2%
Debt ratio change over timeo
0%
Current Ratio
4.63%
Quick Ratio
4.17%
Cash Position Ratio
1.52%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
4.79%
Return on sales
22.66%
Return on invested capital
0%
Total debt ratio
36.05%
Debt ratio change over time
0%
Current Ratio
6.19%
Quick Ratio
5.64%
Cash Position Ratio
2.54%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-19.62%
Return on assets
-91.68%
Return on sales
-447.46%
Return on invested capital
-82.04%
Total debt ratio
-160.42%
Debt ratio change over time
-1.6%
Current Ratio
-2.54%
Quick Ratio
-2.48%
Cash Position Ratio
-2.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GYRE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -75.16% | 13.23% | 9.84% | 26.17% |
| Return on assets | -8.38% | 4.59% | 3.2% | 1.81% |
| Return on sales | -255.59% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | -172.8% | 8.51% | 10.28% | 4.83% |
| Profitability | 0% | 83% | 73% | 67% |
| Total debt ratio | 43.62% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | -1.6% | -16.59% | -73.52% | 21.11% |
| Dept financing | 12% | 22% | 16% | 50% |
| Current Ratio | 4.63% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 4.17% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 1.52% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 11% | 14% | 9% |
| Short-term ratios | GYRE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 2.53% | 5.82% | 4.08% | 0.78% |
| Return on sales | 10.8% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 68% | 50% | 34% | 13% |
| Total debt ratio | 43.2% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 36% | 20% | 15% | 25% |
| Current Ratio | 4.63% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 4.17% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 1.52% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 16% | 19% | 10% |